-
-
-
-
-
-
-
Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
-
-
-
-
-
-
-
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
-
-
-
-
-
-
-
Galapagos (GLPG) appoints Paul Stoffels as Chief Executive Officer
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...)
-
-
-
-
-
-
-
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
-
-
-
-
-
-
-
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
-
-
-
-
-
-
-
Galapagos NV (GLPG) Ticks Higher on Renewed Takeover Speculation
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

